ATE359797T1 - Pharmazeutische zusammensetzung mit chito- oligomeren - Google Patents

Pharmazeutische zusammensetzung mit chito- oligomeren

Info

Publication number: ATE359797T1
Authority: AT; Austria
Prior art keywords: oligomers; pharmaceutical composition; composition containing; treatment; chito
Prior art date: 2001-09-26

Application number

AT02777769T

Other languages

English (en)

Inventor

Jon M Einarsson

Johannes Gislason

Martin Peter

Sven Bahrke

Original Assignee

Genis Ehf

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-26

Filing date

2002-09-26

Publication date

2007-05-15

2002-09-26 Application filed by Genis Ehf filed Critical Genis Ehf

2007-05-15 Application granted granted Critical

2007-05-15 Publication of ATE359797T1 publication Critical patent/ATE359797T1/de

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
208000012659 Joint disease Diseases 0.000 abstract 2
OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 abstract 2
OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 abstract 2
MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
229950006780 n-acetylglucosamine Drugs 0.000 abstract 2
MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 abstract 1
229920002101 Chitin Polymers 0.000 abstract 1
MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 abstract 1
230000006196 deacetylation Effects 0.000 abstract 1
238000003381 deacetylation reaction Methods 0.000 abstract 1
229960002442 glucosamine Drugs 0.000 abstract 1
230000002757 inflammatory effect Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
201000008482 osteoarthritis Diseases 0.000 abstract 1
206010039073 rheumatoid arthritis Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
- C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Biochemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Genetics & Genomics (AREA)
Polymers & Plastics (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Biotechnology (AREA)
Materials Engineering (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

AT02777769T 2001-09-26 2002-09-26 Pharmazeutische zusammensetzung mit chito- oligomeren ATE359797T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IS6085A IS6085A (is)	2001-09-26	2001-09-26	Lyfjablanda með kítósan óligómerum

Publications (1)

Publication Number	Publication Date
ATE359797T1 true ATE359797T1 (de)	2007-05-15

Family

ID=36700489

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02777769T ATE359797T1 (de)	2001-09-26	2002-09-26	Pharmazeutische zusammensetzung mit chito- oligomeren

Country Status (13)

Country	Link
US (2)	US7985741B2 (de)
EP (1)	EP1435976B1 (de)
JP (1)	JP4613008B2 (de)
KR (1)	KR20040062548A (de)
AT (1)	ATE359797T1 (de)
CA (1)	CA2507926C (de)
DE (1)	DE60219653T2 (de)
DK (1)	DK1435976T3 (de)
ES (1)	ES2284935T3 (de)
IS (2)	IS6085A (de)
PT (1)	PT1435976E (de)
SI (1)	SI1435976T1 (de)
WO (1)	WO2003026677A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050070500A1 (en) *	2001-12-13	2005-03-31	Boucher L Isabelle	Method of modulating release of saccharides and uses thereof
GB0321996D0 (en) *	2003-09-19	2003-10-22	Novartis Nutrition Ag	Organic compounds
JP2007507516A (ja) *	2003-10-01	2007-03-29	オプティマー・ファーマスーティカルズ・インコーポレイテッド	アミノ糖投与による哺乳動物の障害の治療及びアミノ糖の使用
US20070082851A1 (en) *	2003-11-24	2007-04-12	Optimer Pharmaceuticals Inc.	Treatment of a condition in a mammal with administration of Compounds and Methods of Use
CA2551613A1 (en) *	2004-05-21	2005-12-01	Tottori University	A composition comprising n-acetyl-d-glucosamine for treatment of wound
MX336736B (es) *	2005-06-14	2016-01-29	Genis Hf	Composiciones de derivados de quitina parcialmente desacetilados.
US7485718B2 (en)	2005-06-16	2009-02-03	E. I. Du Pont De Nemours And Company	Chemical synthesis of low molecular weight polyglucosamines and polygalactosamines
WO2007001282A2 (en) *	2005-06-16	2007-01-04	E.I. Dupont De Nemours And Company	Low molecular weight polyglucosamines and polygalactosamines
KR100831335B1 (ko) *	2006-06-22	2008-05-22	부경대학교 산학협력단	인간 피부 섬유아세포에서 메트릭스메탈로프로테이나제-2의 발현 및 활성을 억제시키는키토올리고사카라이드 화합물 및 이를 함유한 메트릭스메탈로프로테이나제-2 억제제
EP2318014B1 (de) *	2008-07-18	2016-09-14	Genís hf.	Neue chito-oligomer zubereitung zur medizinischen verwendung
KR20100060634A (ko) *	2008-11-28	2010-06-07	(주)아모레퍼시픽	미토콘드리아 활성화를 위한 조성물
KR101729137B1 (ko) *	2009-07-28	2017-04-26	(주)아모레퍼시픽	키토올리고당을 함유하는 피로회복용 조성물
US9186377B2 (en)	2011-06-03	2015-11-17	Maguire Abbey, Llc	Method, composition, and articles for improving joint lubrication
EP3058826A1 (de)	2011-09-08	2016-08-24	Novozymes BioAG A/S	Saatgutbehandlungsverfahren
PL2748123T3 (pl)	2011-09-14	2024-05-13	Novozymes Bioag A/S	Zastosowanie lipochito-oligosacharydów i/lub chito-oligosacharydów w kombinacji z mikroorganizmami solubilizującymi fosforany do poprawy wzrostu roślin
AU2012312006B2 (en) *	2011-09-23	2015-10-29	Novozymes Bioag A/S	Chitooligosaccharides and methods for use in enhancing corn growth
CA2849898C (en)	2011-09-23	2020-10-27	Novozymes Bioag A/S	Chitooligosaccharides and methods for use in enhancing plant growth
US9474828B2 (en)	2012-04-23	2016-10-25	Genis Hf.	Self-hardening bioactive cement compositions with partially deacetylated chitin as bone graft substitutes
JP6285497B2 (ja) *	2016-06-07	2018-02-28	株式会社エバーライフ	鶏冠抽出物含有経口組成物及び鶏冠抽出物の香味に由来する摂取困難性の改善方法
KR101673368B1 (ko)	2016-07-14	2016-11-08	김기혁	공정가스 반응물의 콜드트랩 장치
EP4511042A4 (de) *	2022-04-21	2026-04-22	Therapeutikos Inc	Verfahren zur behandlung von entzündungen

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5919122B2 (ja) *	1976-10-12	1984-05-02	味の素株式会社	水溶性部分脱アセチル化キチン及びその製造法
US4532134A (en) *	1981-04-06	1985-07-30	Malette William Graham	Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
JP2527317B2 (ja) *	1986-12-19	1996-08-21	ライオン株式会社	骨疾患治療剤
US6184037B1 (en) *	1996-05-17	2001-02-06	Genemedicine, Inc.	Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell
DE69733089T2 (de) *	1996-12-13	2005-09-29	Lescarden Inc.	Behandlung der osteoarthritis durch verabreichung von poly-n-acetyl-d-glucosamin
JP3062592B2 (ja) *	1997-05-30	2000-07-10	農林水産省食品総合研究所長	２−アセチルアミノ−４−Ｏ−（２−アミノ−２−デオキシ−β−Ｄ −グルコピラノシル）−２−デオキシ−Ｄ −グルコースおよびその塩の製造法
US6492350B2 (en) *	2000-01-27	2002-12-10	Jdc (Hawaii) Inc.	Chitin oligosaccharides and/or chitosan oligosaccharides for preventing or treating common cold or treating pain
EP1127574A1 (de) *	2000-02-22	2001-08-29	Food Industry Research and Development Institute	Verwendung von Chitin-enthaltenden Produkten zur Hemmung von der Erzeugung von NO
CA2313836C (en) *	2000-03-15	2009-06-09	Cargill, Incorporated	Chitosan and method of preparing chitosan
US20020119949A1 (en)	2001-02-26	2002-08-29	Asa Hellman	Prophylactic teat treatment
MX336736B (es) *	2005-06-14	2016-01-29	Genis Hf	Composiciones de derivados de quitina parcialmente desacetilados.

2001
- 2001-09-26 IS IS6085A patent/IS6085A/is unknown
2002
- 2002-09-26 DE DE60219653T patent/DE60219653T2/de not_active Expired - Lifetime
- 2002-09-26 WO PCT/IS2002/000016 patent/WO2003026677A1/en not_active Ceased
- 2002-09-26 PT PT02777769T patent/PT1435976E/pt unknown
- 2002-09-26 KR KR10-2004-7004323A patent/KR20040062548A/ko not_active Ceased
- 2002-09-26 US US10/490,637 patent/US7985741B2/en active Active
- 2002-09-26 DK DK02777769T patent/DK1435976T3/da active
- 2002-09-26 ES ES02777769T patent/ES2284935T3/es not_active Expired - Lifetime
- 2002-09-26 CA CA2507926A patent/CA2507926C/en not_active Expired - Lifetime
- 2002-09-26 EP EP02777769A patent/EP1435976B1/de not_active Expired - Lifetime
- 2002-09-26 JP JP2003530312A patent/JP4613008B2/ja not_active Expired - Lifetime
- 2002-09-26 SI SI200230558T patent/SI1435976T1/sl unknown
- 2002-09-26 AT AT02777769T patent/ATE359797T1/de active
2004
- 2004-03-22 IS IS7193A patent/IS2783B/is unknown
2011
- 2011-06-20 US US13/164,397 patent/US8415326B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP1435976A1 (de)	2004-07-14
US8415326B2 (en)	2013-04-09
ES2284935T3 (es)	2007-11-16
US20110257381A1 (en)	2011-10-20
SI1435976T1 (sl)	2007-08-31
DE60219653D1 (de)	2007-05-31
DE60219653T2 (de)	2008-01-03
JP4613008B2 (ja)	2011-01-12
PT1435976E (pt)	2007-06-28
WO2003026677A1 (en)	2003-04-03
IS7193A (is)	2004-03-22
CA2507926C (en)	2011-12-20
US20050004073A1 (en)	2005-01-06
DK1435976T3 (da)	2007-08-27
IS2783B (is)	2012-05-15
JP2005507891A (ja)	2005-03-24
US7985741B2 (en)	2011-07-26
EP1435976B1 (de)	2007-04-18
CA2507926A1 (en)	2003-04-03
KR20040062548A (ko)	2004-07-07
IS6085A (is)	2003-03-27

Legal Events

Date

Code

Title

Description

2007-10-15

UEP

Publication of translation of european patent specification

Ref document number: 1435976

Country of ref document: EP

Publication	Publication Date	Title
DK1435976T3 (da)	2007-08-27	Farmaceutisk sammensætning indeholdende chito-oligomerer
IL150257A0 (en)	2002-12-01	Galactomaninan oligosaccharides, pharmaceutical compositions containing the same and methods for the production thereof
DZ3165A1 (fr)	2000-12-07	Composition alimentaire ou pharmaceutique utiliseepour prevenir ou traiter l'hyperoxalurie.
EP2085780A3 (de)	2011-08-17	Verfahren und Produkte die mit niedermolekularem Heparin assoziiert sind
BG101209A (bg)	1997-08-29	Хиполипидемични 1,4-бензотиазепин-1,1-диоксиди
NO20012000D0 (no)	2001-04-23	N-(2-aryl-propionyl)-sulfonamider og farmasöytiske sammensetninger som inneholder dem
SE0102315D0 (sv)	2001-06-28	Compounds
MY140840A (en)	2010-01-29	Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
FR2842201B1 (fr)	2005-01-14	Nouvel oligosaccharide, compositions cosmetiques et/ou dermatologiques en contenant et ses applications
BR9913658A (pt)	2001-06-05	Frações de inulina, processo para a sua preparação e produtos alimentìcios contendo as ditas frações de inulina
WO2004105737A3 (en)	2005-06-09	Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
DE60313004D1 (de)	2007-05-16	Alpha-7-nikotinsäure-rezeptoragonisten und statine in kombination
GB0310919D0 (en)	2003-06-18	Pharmaceutical compositions
NO20056161L (no)	2005-12-23	Formuleringer for behandling av artrittilstander
JP2005507891A5 (de)	2006-01-12
NO20035035D0 (no)	2003-11-13	Citrasalt av 5,8,14-triazatetracyklo (10.3.1.0 opphöyet 2,11 .0 opphöyet 4,9) - heksadeca-2. (11), 3,5,7,9-pentaen og farmasöytiskesammensetninger derav
IS6914A (is)	2003-08-15	2-þíó-útskiptar imídasólafleiður og notkun þeirraí lyfjaiðnaðinum
NO20010940L (no)	2001-04-23	TAN-1057 derivater
TW200510012A (en)	2005-03-16	Aqua gel comprising temperature effect
ITMI20021801A1 (it)	2004-02-09	Prodotti di pomodoro.
NO985414L (no)	1999-01-19	Farmas÷ytiske formuleringer inneholdende kalium-, natrium- og trioksaprozin salt
EP1411956B8 (de)	2005-10-05	Verwendung von übersulfatierten polysacchariden als hiv-hemmer
DE60206940D1 (de)	2005-12-01	Pektin und ascorbinsäure enthaltende zusammensetzungen
EP2301554A8 (de)	2011-10-26	Zusammensetzung zur Behandlung von Osteoartritis
FR2857026B1 (fr)	2012-11-16	Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant